SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-072709
Filing Date
2024-03-20
Accepted
2024-03-20 16:13:04
Documents
15
Period of Report
2024-03-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d814195d8k.htm   iXBRL 8-K 27608
2 EX-3.1 d814195dex31.htm EX-3.1 7011
3 EX-3.2 d814195dex32.htm EX-3.2 20774
  Complete submission text file 0001193125-24-072709.txt   187669

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA advm-20240320.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20240320_lab.xml EX-101.LAB 17981
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20240320_pre.xml EX-101.PRE 11259
19 EXTRACTED XBRL INSTANCE DOCUMENT d814195d8k_htm.xml XML 3723
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 24767932
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)